ClearPoint Neuro (NASDAQ: CLPT) reported second-quarter 2026 revenue growth while outlining a shift

ClearPoint Neuro's second quarter results were poor across the board, with drug delivery disposables

Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 415.3% to $18.81 during Tuesday's regular se

U.S. stocks gain with Nasdaq up more than 2% on Tuesday. Dow up 1.79% to 54,129.35, Nasdaq up 2.22%

Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday'

U.S. stock futures rise on Tuesday, but Powell Industries Inc shares fall 13.4% after reporting lowe

Palantir Technologies Inc (PLTR) shares jumped 16.1% in pre-market trading on upbeat Q2 results, wit

ClearPoint Neuro, Inc. (CLPT) Q2 2026 Earnings Call Transcript

The headline numbers for ClearPoint Neuro (CLPT) give insight into how the company performed in the

ClearPoint Neuro, Inc. (CLPT) came out with a quarterly loss of $0.38 per share versus the Zacks Con

ClearPoint Neuro NASDAQ: CLPT reported second-quarter 2026 revenue growth while outlining a shift in

Gainers Ensysce Biosciences (NASDAQ:ENSC) stock rose 118.1% to $0.61 during Monday's after-mark

ClearPoint Neuro (NASDAQ:CLPT) lowers FY2026 sales outlook from $52.000 million-$56.000 million to $

ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.38) per share which missed the analy

Positive BioPharma Partner Regulatory Progress and Early Success in Focused Ultrasound Technology Pl

 RMAT Designation Supports an Expedited FDA Development and Review Pathway for Aspen's Investiga

RMAT Designation Supports an Expedited FDA Development and Review Pathway for Aspen's Investigationa

SOLANA BEACH, CA / ACCESS Newswire / July 21, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Comp

B. Riley Securities analyst Anderson Schock maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy a

ClearPoint Neuro remains a speculative Buy, offering leveraged exposure to gene therapy commercializ

ClearPoint Neuro (CLPT) saw its shares surge in the last session with trading volume being higher th

U.S. stocks rose, with the Dow Jones gaining 200 points on Wed. Jabil Inc (JBL) shares surged 9.8% a

ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-en

Announcement is made after successful proof-of-concept trial in a preclinical model of intravenous d

ClearPoint Neuro, Inc. (CLPT) Q1 2026 Earnings Call Transcript

Although the revenue and EPS for ClearPoint Neuro (CLPT) give a sense of how its business performed

ClearPoint Neuro, Inc. (CLPT) came out with a quarterly loss of $0.32 per share versus the Zacks Con

ClearPoint Neuro NASDAQ: CLPT reported record first-quarter 2026 revenue and reaffirmed its full-yea

Record Revenue Achieved Including 25% Organic Growth in Devices and 43% Overall Growth SOLANA BEACH,

SOLANA BEACH, CA / ACCESS Newswire / May 13, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company")

https://subscriber.politicopro.com/article/2026/05/makarys-time-atop-fda-over-tktk-named-acting-comm

https://www.cbsnews.com/news/trump-approves-plan-to-fire-fda-commissioner-marty-makary/?intcid=CNM-0

Pre-Market Stock Futures: Futures are trading higher as we get set to end what has been one of the w

SOLANA BEACH, CA / ACCESS Newswire / April 29, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Com

ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-en

B. Riley Securities analyst Neil Chatterji maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy an

Dow futures up 200 points, ClearPoint Neuro (CLPT) stock falls after wider-than-expected quarterly l

Energy Vault Holdings Inc (NYSE: NRGV) rose in pre-market trading after beating earnings estimates a

ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.23) per share which missed the analy

ClearPoint Neuro (NASDAQ:CLPT) lowers FY2026 sales outlook from $54.000 million-$60.000 million to $

ClearPoint Neuro (NASDAQ:CLPT) reported quarterly sales of $10.400 million which beat the analyst co

B. Riley Securities analyst Neil Chatterji maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy an

ClearPoint Neuro receives EU certification for its navigation software, expanding brain surgery acce